Derrell Porter - SVP, Atara Biotherapeutics, Inc

As of March 27, 2019


Derrell Porter Net Worth

  • Net worth is estimated to be at least $1.35M
  • Owns at least 21,688 units of Atara Biotherapeutics, Inc stock
  • Sold an estimated value of $1.08M in the last 2 years at Atara Biotherapeutics, Inc

Derrell Porter Trading

  • Largest purchase of shares was 16,334 units , worth over $233.58K on May 16, 2018
  • Largest sale of shares was 16,334 units , worth over $735.36K on May 16, 2018
  • In total has made about 7 transactions over 2 years
  • Usually trades in February and May, with the busiest year in 2019 and 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Derrell Porter Mailing Address

  • Mailing address is C/o Atara Biotherapeutics, Inc. 611 Gateway Blvd. #900 South San Francisco CA 94080 CA

Atara Biotherapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Pascal Touchon, D.V.M. 2020 $654,857 $422,500 $2,235,600 $1,959,208 $13,662 $5,285,827
Pascal Touchon, D.V.M. 2019 $319,327 $334,791 $2,861,712 $3,049,718 $71,760 $6,637,307
Jakob Dupont, M.D. 2020 $319,231 $143,346 $443,075 $1,757,296 $133,297 $2,796,245
Utpal Koppikar 2020 $460,947 $187,032 $885,431 $597,073 $7,470 $2,137,953
Utpal Koppikar 2019 $439,875 $155,606 $1,034,714 $909,080 $895 $2,540,170
Utpal Koppikar 2018 $240,289 $189,771 $1,903,500 $1,886,325 $398 $4,220,282
Joseph Newell 2020 $466,055 $203,435 $1,033,965 $566,713 $895 $2,251,063
Joseph Newell 2019 $390,000 $155,208 $1,240,675 $932,390 $895 $2,719,167
Joseph Newell 2018 $365,000 $155,490 $895,000 $1,060,710 $16,092 $2,492,292
Kristin Yarema, Ph.D. 2020 $368,308 $147,995 $668,250 $1,067,484 $184,370 $2,436,407
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1604464/000156459021020128/atra-def14a_20210608.htm

Atara Biotherapeutics, Inc Insider Trading

  • The most recent transaction was 3,223 units sold on May 19, 2022 by Amar Murugan worth over $17.13K
  • In the last 8 years, insiders at Atara Biotherapeutics, Inc sold an estimated value of $72.85M and bought an estimated value of $10.47M
  • The most active traders are Isaac E Ciechanover, Chief Executive Officer,  Christopher Haqq, EVP,  and Joe Newell, Chief Operations Officer
  • Insider trading is most common in February, with the busiest year in 2018

Atara Biotherapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1